Core Scientific, Inc.
CORZQ
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.03M | 27.22M | 30.36M | 29.33M | 29.76M |
| Total Other Revenue | 79.90M | 68.14M | 110.74M | 149.96M | 112.17M |
| Total Revenue | 94.93M | 95.35M | 141.10M | 179.29M | 141.93M |
| Cost of Revenue | 85.86M | 90.68M | 99.19M | 101.65M | 102.63M |
| Gross Profit | 9.06M | 4.68M | 41.91M | 77.65M | 39.30M |
| SG&A Expenses | 42.88M | 42.34M | 32.31M | 15.13M | 28.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 805.00K | 206.00K | 1.12M | 1.68M | 3.93M |
| Total Operating Expenses | 134.56M | 136.06M | 134.79M | 120.24M | 136.55M |
| Operating Income | -39.63M | -40.71M | 6.31M | 59.05M | 5.38M |
| Income Before Tax | -265.17M | -455.13M | -804.75M | 210.90M | -195.36M |
| Income Tax Expenses | 375.00K | 134.00K | 144.00K | 206.00K | 336.00K |
| Earnings from Continuing Operations | -265.54M | -455.26M | -804.90M | 210.69M | -195.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -265.54M | -455.26M | -804.90M | 210.69M | -195.69M |
| EBIT | -39.63M | -40.71M | 6.31M | 59.05M | 5.38M |
| EBITDA | -13.59M | -12.02M | 35.79M | 88.04M | 36.58M |
| EPS Basic | -0.60 | -1.17 | -4.51 | 0.91 | -0.51 |
| Normalized Basic EPS | -0.55 | -0.97 | -2.82 | 0.28 | -0.13 |
| EPS Diluted | -0.60 | -1.17 | -4.51 | 0.78 | -0.51 |
| Normalized Diluted EPS | -0.55 | -0.97 | -2.82 | 0.23 | -0.13 |
| Average Basic Shares Outstanding | 306.15M | 292.49M | 178.51M | 230.95M | 385.07M |
| Average Diluted Shares Outstanding | 306.15M | 292.49M | 178.51M | 282.53M | 385.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
